Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Precision Cancer Imaging Market Revenue Growth Supported By A CAGR Of 31.71% Through 2030
The precision cancer imaging market has experienced rapid expansion in recent years. It is projected to grow from $17.39 billion in 2025 to $19.58 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 12.6%. The historical growth in this market can be attributed to a rising prevalence of cancer cases, progress in molecular imaging technologies, increased adoption of PET and MRI systems, the development of hospital diagnostic infrastructure, and an increase in government-led cancer screening initiatives.
The precision cancer imaging market is expected to demonstrate significant expansion in the coming years. Its size is predicted to reach $31.71 billion by 2030, growing at a compound annual growth rate (CAGR) of 12.8%. This growth during the forecast period is driven by factors such as the increasing demand for personalized oncology treatments, the expansion of AI-driven imaging analytics, escalating investments in precision medicine research, a rising adoption of cloud-based imaging platforms, and the increasing development of non-invasive diagnostic solutions. Noteworthy trends for the forecast period include the widespread adoption of precision oncology imaging, the integration of hybrid imaging systems, the development of multi-modal diagnostic workflows, tumor characterization based on radiomics, and advancements in early-stage cancer detection.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample_request?id=25235913&type=smp
Precision Cancer Imaging Market Growth Momentum: Which Factors Are Influencing Demand?
An increase in cancer cases is anticipated to drive the expansion of the precision cancer imaging market in the future. This rise in cancer incidence largely stems from an aging demographic, given that older people face an elevated risk of cancer development due to the buildup of genetic mutations and extended exposure to various risk factors over their lifetime. Precision cancer imaging supports cancer management through facilitating earlier detection, more precise tumor localization, and customized treatment strategies, which enhance treatment effectiveness and minimize superfluous procedures. For example, in February 2024, the World Health Organization, an international body based in Switzerland focused on global health policy and public health, projected more than 35 million new cancer diagnoses by 2050. This represents a 77% surge from the approximately 20 million cases recorded in 2022. Consequently, the increasing occurrence of cancer cases is fueling the expansion of the precision cancer imaging market.
Precision Cancer Imaging Market Segmentation And Category Breakdown
The precision cancer imaging market covered in this report is segmented –
1) By Component: Hardware, Software, Services
2) By Cancer Type: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Other Cancer Types
3) By Imaging Modality: Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), Other Modalities
4) By Application: Cardiovascular, Neurology, Gastroenterology, Infectious Diseases, Oncology, Other Applications
5) By End-user: Hospitals And Clinics, Diagnostic Imaging Centers, Ambulatory Surgical Centers, Other End-users
Subsegments:
1) By Hardware: Imaging Systems, Detection Devices, Radiation Equipment, Biopsy Guidance Systems, Monitoring Devices
2) By Software: Image Analysis Software, Visualization Software, Data Management Software, Diagnostic Software, Reporting Software
3) By Services: Imaging Services, Consulting Services, Maintenance Services, Training Services, Integration Services
Precision Cancer Imaging Market Trends Reshaping Industry Growth
Major companies in the precision cancer imaging market are concentrating on utilizing innovative technologies, such as artificial intelligence-built imaging platforms, to improve diagnostic precision and simplify cancer treatment planning. These artificial intelligence-built imaging platforms are advanced CT and MR systems that leverage machine learning algorithms to enhance image reconstruction, tumor detection, and anatomical visualization. This helps clinicians achieve faster, more accurate diagnoses and more precise cancer treatment planning. For example, in September 2025, Koninklijke Philips N. V., a Netherlands-based health technology company, unveiled its latest CT and MR solutions at the American Society for Radiation Oncology (ASTRO) 2025 meeting, specifically designed to advance precision cancer care. These platforms feature ultra-fast AI-assisted reconstruction, helium-free MR systems for sustainable operation, extended field-of-view 4D imaging, and intuitive interfaces that streamline radiation therapy planning while improving patient comfort. By combining high image quality with efficient workflows, these innovations enable oncology teams to deliver personalized treatment with greater confidence and precision.
Precision Cancer Imaging Market Competitive Analysis Of Major Industry Participants
Major companies operating in the precision cancer imaging market are Hitachi Medical Corporation, Thermo Fisher Scientific Inc., Siemens Healthineers AG, FUJIFILM Holdings Corporation, Koninklijke Philips N. V., GE HealthCare Technologies Inc., Shimadzu Corporation, Agilent Technologies Inc., Mindray Bio-Medical Electronics Co Ltd., Bruker Corporation, Canon Medical Systems Corporation, Shanghai United Imaging Healthcare Co Ltd., Agfa-Gevaert N. V., Hologic Inc., Carestream Health Inc., Perceptive Discovery, Esaote S. p. A., Alliance Medical Group, Quibim S. L., Mediso Ltd
Access The Complete Precision Cancer Imaging Market Report:
https://www.thebusinessresearchcompany.com/report/precision-cancer-imaging-market-report
Precision Cancer Imaging Market Geographic Distribution And Regional Opportunities
North America was the largest region in the precision cancer imaging market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision cancer imaging market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.